Annual revenues of Swedish biopharma company Sobi increased from around 6.5 billion Swedish kronor in 2017, up to the highest value of around 15.5 billion Swedish kronor in 2021. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases. This statistic illustrates the annual revenue of Sobi from 2009 to 2021.
Annual revenue of Sobi from 2009 to 2021
(in million SEK)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.